Celsion rebrands to Imunon

Celsion Corporation announced Monday that it will change its name to Imunon.

The clinical-stage drug development biotech said the move is intended to reflect the “evolution of the company’s business focus” as well as its commitment to developing immunotherapies and next-generation vaccines.